Publications

Detailed Information

Potentiation of porcine circovirus 2-induced postweaning multisystemic wasting syndrome by porcine parvovirus is associated with excessive production of tumor necrosis factor-alpha

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors

Kim, J.; Ha, Y.; Chae, Chan Hee

Issue Date
2006
Publisher
American College of Veterinary Pathologists
Citation
Vet Pathol 43:718-725, 2006
Keywords
Porcine circovirusporcine parvoviruspostweaning multisystemic wasting syndromeswinetumor necrosis factor-a
Abstract
This study investigated the potentiation of porcine circovirus 2 (PCV2)-induced
postweaning multisystemic wasting syndrome by porcine parvovirus (PPV) and found it was associated
with excessive production of tumor necrosis factor-a (TNF-a). Colostrum-deprived conventional pigs
were inoculated intranasally with PCV2 or PPV alone or in combination (PCV2 and PPV). In vitro assay
of TNF-a, obtained from alveolar macrophages coinfected with PCV2 and PPV, showed a significant
increase in TNF-a compared to single infection of macrophages with either PCV2 or PPV alone (P ,
0.05). All pigs inoculated with PCV2 and PPV developed severe postweaning wasting syndrome, whereas
clinical signs (e.g., weight loss) were present but perhaps less severe in either PCV2- or PPV-inoculated
pigs. Compared to the pigs inoculated with PCV2 or PPV alone, pigs inoculated dually with PCV2 and
PPV showed significantly (P , 0.05) increased levels of TNF-a. Levels of TNF-a in the sera were
reversely correlated with the body weight in pigs experimentally infected with dual inoculation of PCV2
and PPV (rs 5 20.92, P , 0.001). These data suggest that a potentiation of PPV in PCV2-induced
PMWS is associated with the excessive production of TNF-a.
ISSN
0300-9858
Language
English
URI
http://www.vetpathology.org/cgi/content/abstract/43/5/718

https://hdl.handle.net/10371/6549
Files in This Item:
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share